Anthem Biosciences Ltd. Share Price

Overview

Anthem Biosciences Ltd. share price is currently ₹807.86, up by ₹15.03 (1.9%) from its previous closing price of ₹792.83. The share price has declined -8.3% over the past month and gained 5.28% over the past year. The stock's 52-week low and high are ₹570.99 and ₹967.44, respectively. Anthem Biosciences Ltd. has a market capitalisation of ₹ 46,330.00 Cr. The share price was last updated on 23 Oct 2026, 03:51 PM IST.

Anthem Biosciences Ltd.
Anthem Biosciences Ltd.
ANTHEM
 ₹0.00
 ₹15.03
1.90%
Healthcare
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:51:56 pm IST

Market Data

Open Price

 ₹795.39

Prev. Close

 ₹792.83
 ₹778.65

Day Low

 ₹812.86

Day High

 ₹570.99

52 Week Low

 ₹967.44

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

78.82

Sector PE

41.82

PB Ratio

15.08

Sector PB

5.48

EPS

10.25

Dividend Yield

0.30

Today's Volume

534.645 K

5 Day Avg. Volume

447.736 K

PEG Ratio

2.58

Market Cap.

₹ 46,330.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 100% at ₹2/Share
25-Jun-202626-Jun-2026

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
HDFC Flexi Cap Fund - Growth77.66 Lac
74.00 Lac
(4.71%)
SBI Midcap Fund - Regular Plan - Growth43.18 Lac
43.18 Lac
no change
Axis ELSS - Tax Saver Fund - Regular Plan - Growth29.22 Lac
29.22 Lac
no change
Aditya Birla Sun Life Flexi Cap Fund - Regular Plan - Growth24.50 Lac
24.50 Lac
no change
SBI MNC Fund - Regular Plan - IDCW23.20 Lac
22.00 Lac
(5.17%)

About Anthem Biosciences Ltd. 👋

Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company's segments include CRDMO and Speciality Ingredients. The Company helps new and established biotech's and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and others. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its CRDMO Services include Large Molecules, Small Molecules, HPAPI, Peptides, Lipids, ADCs and Oligonucleotides.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Manjushri Sharma SEBI RA

Manjushri Sharma SEBI RA

12 Oct • 5:07 PM · SEBI-Registered Analyst

ANTHEM Biosciences attracted market attention

ANTHEM
ANTHEM Biosciences attracted market attention following a significant bulk deal reported on October 12 2026. According to market reports Portsmouth Technologies LLC sold approximately 30 lakh shares of the company at ₹833 per share. The transaction represents an estimated value of ₹249.9 crore making it a notable institutional ownership development for the stock. Investors may monitor subsequent exchange disclosures to understand any changes in the company's shareholding pattern. Bulk deals can influence short-term price movements by changing market sentiment and trading volumes. However a large transaction alone does not establish whether the stock is fundamentally strong or weak. Investors should also evaluate revenue growth profitability business prospects and valuation before drawing conclusions. Market participants should track the stock's price behaviour delivery volumes and official exchange announcements to assess how the market absorbs the transaction. Important Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Please verify transaction details through official exchange filings before making investment decisions. Investments are subject to market risks.

See More
VIJAY KUMAR GUPTA

VIJAY KUMAR GUPTA

7 Aug • 3:43 PM · SEBI-Registered Analyst

ANTHEM
Anthem Biosciences Ltd: A large Indian Contract Research, Development, and Manufacturing Organization (CRDMO)

ANTHEM
Anthem Biosciences Ltd: A large Indian Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in drug discovery, chemical synthesis, and biologics with a market value around ₹47,000 ***** Investment & Infrastructure Ltd: A listed Indian Non-Banking Financial Company (NBFC) involved in corporate investments, asset management, and equity ***** AI: A modern technology startup operating a crowdsourced platform that connects commercial brands with AI video content creators for short-form ***** (Apparel): An independent lifestyle clothing brand focused on premium casual wear and organic cotton streetwear garments.

See More
Finkhoz Roboadvisory Services

Finkhoz Roboadvisory Services

3 Aug • 9:07 AM · SEBI-Registered Analyst

Analysts Identify Fresh Breakout Opportunities as Market Momentum Improves

With the Nifty extending its winning streak and market breadth remaining positive, technical analysts expect the benchmark indices to continue moving towards their previous swing highs. In this backdrop, experts have identified several stocks—including

HEROMOTOCO
,
ANANTRAJ
,
ANTHEM
,
KEI
,
ESCORTS
,
BLSE
and others—as potential short-term trading opportunities, citing bullish chart patterns, breakout formations and improving momentum. Investors are advised to focus on stocks showing strong technical strength

See More
Kundan Motwani

Kundan Motwani

22 Jul • 10:20 AM · SEBI-Registered Analyst

ANTHEM BIOSCIENCES:

CO SAYS CONFIDENT OF RETURNING TO MID-TEENS GROWTH

ANTHEM

Pradeep Carpenter

Pradeep Carpenter

21 Jul • 8:55 AM · SEBI-Registered Analyst

Morning Market Insights:

Indian Markets are under same continuing zones inside the consolidating range and is looking neutral on the charts with stock specific action continuing in the mid and small cap space. The overall sentiment is expected to remain cautious for the day with support for the index pegged around 23900 and 23950 while 24300 and 24350 remains resistance zones. Bank Nifty is also expected to consolidate after the yesterday’s sell off and stock specific action is expected to continue within the index. The index is having crucial support zones of 57200-57300 below which the index 56800 is the next small support while 58000-58200 remains resistance for the day. Q1 FY27 Results Today – 21 July 2026

BAJAJ-AUTO
Adani Energy Solutions Adani Total Gas
TVSMOTOR
Bandhan Bank Aditya Birla Sun Life AMC CRISIL Granules India Gabriel India AAVAS Financiers Anthem Biosciences Cyient DLM
ARVINDFASN
E2E Networks Ador Welding Atlanta Electricals

See More
AALGO BREATHS I SEBI RA

AALGO BREATHS I SEBI RA

17 Jul • 12:33 PM · SEBI-Registered Analyst

Anthem Biosciences Ltd – Bullish Setup

ANTHEM
The stock is showing fresh buying interest after consolidating near support, indicating a potential upside move. 🔎 Technical Observations: • Consolidation near key support • Strong bullish candle breakout • Price above short-term averages • Momentum improving 🔑 Key Levels: • Support: ₹755 – ₹740 • Major Support: ₹716 – ₹697 • Resistance: ₹786 – ₹800 🚀 Targets: • ₹800 • ₹834 • ₹854+ 📉 Risk: A close below ₹740 may weaken the bullish setup. 📈 Trading View: 👉 Sustaining above ₹786 can trigger fresh buying towards higher targets. ⚠️ For educational purposes only. Not a buy/sell recommendation. — AALGO BREATHS 📊

See More

Frequently Asked Questions

What is the share price of Anthem Biosciences Ltd.?

What is the market cap of Anthem Biosciences Ltd.?

Should I buy Anthem Biosciences Ltd. stock now?

What is the 52 week high and low of Anthem Biosciences Ltd.?

Is the Anthem Biosciences Ltd. stock good to buy?

Is Anthem Biosciences Ltd. a good buy for the long term?

Is Anthem Biosciences Ltd. overvalued or undervalued?

What is the PE and PB ratio of Anthem Biosciences Ltd.?

Start Now